The ultrasound group of Siemens Medical Systems will roll outa new line of scanners designed to establish the division as amajor player in the ultrasound market. The line includes the long-awaitedSonoline Elegra premium scanner (SCAN 4/26/95). Elegra is
The ultrasound group of Siemens Medical Systems will roll outa new line of scanners designed to establish the division as amajor player in the ultrasound market. The line includes the long-awaitedSonoline Elegra premium scanner (SCAN 4/26/95).
Elegra is based on digital beamformer technology and employs128 channels, according to Lothar Koob, vice president of theultrasound group. Siemens has developed synthetic aperture softwaretechniques that enable Elegra to perform as though it has 256channels, Koob said. The scanner's output will be DICOM-compliantwithout the need for an interface box. Siemens has applied forFood and Drug Administration clearance for Elegra.
Sonoline Prima is an entry-level gray-scale scanner that replacesthe Sonoline 250, 400 and 450 scanners. Both Elegra and Primacomplement the mid-range Sonoline Versa system introduced lastyear (SCAN 11/23/94).
The nuclear medicine group of Siemens will display several newtechnologies targeted at reestablishing the vendor's leadershipin the modality. The group will feature the open-architectureDiacam and MultiSPECT cameras, as well as its digital detectortechnology and Mµsic simultaneous attenuation correctionprotocol.
In digital image management, Siemens will concentrate on alliancesestablished with other Siemens groups that specialize in telecommunicationstechnology. The PACS group is working with Siemens Rolm, a networkservices company that has a wireless phone that can be used toset up a private phone network in a hospital. Another Siemensgroup, Siemens Systems Integration, has experience designing LANand WAN systems.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.